Back to search

Democritus University of Thrace (DUTH)

Μελέτη της χρόνιας φλεγμονής και της ανοσολογικής απόκρισης στον εποχικό αντιγριπικό εμβολιασμό σε ασθενείς υπό χρόνια περιοδική αιμοκάθαρση: σύγκριση και πιθανά πλεονεκτήματα της online αιμοδιαδιήθησης σε σχέση με την κλασσική αιμοκάθαρση

Abstract

dc:description

A. Background: Chronic inflammation and suboptimal immune responses to vaccinations are considered to be aspects of immune dysregulation in patients that are undergoing dialysis. The present study aimed to evaluate immune responses in hemodialysis (HD) and online hemodiafiltration (OL-HDF) patients to a seasonal inactivated quadrivalent influenza vaccine (IQIV). B. Methods: We enrolled 172 chronic dialysis patients (87 on HD and 85 on OL-HDF) and 18 control subjects without chronic kidney disease in a prospective, cross-sectional cohort study. Participants were vaccinated with a seasonal IQIV, and antibody titers using the hemagglutination inhibition (HI) assay were determined before vaccination (month 0) and 1, 3, and 6 months thereafter. Demographics and inflammatory markers (CRP, IL-6, IL-1) were recorded at month 0. The primary endpoints were the rates of seroresponse (SR), defined as a four-fold increase in the HI titer, and seroprotection (SP), defined as HI titer > 1/40 throughout the study period. Statistical analyses were conducted in R (version 3.6.3) statistical software. The differences between groups were analyzed using chi-square and t-test analyses for dichotomous and continuous variables, respectively. To identify independent determinants of SR and SP, generalized linear models were built with response or protection per virus strain as the dependent variable and group, age, sex, time (month 0, 1, 3, 6), diabetes, IL-6, dialysis vintage, HD access, and HDF volume as independent explanatory variables. C. Results: SR and SP rates were similar between control subjects and dialysis patients, and were not affected by dialysis modality. SP rates were high (> 70%) at the beginning of the study and practically reached 100% after vaccination in all study groups. These results applied to all four virus strains that were included in the IQIV. IL-6 levels significantly differed between study groups, with HD patients displaying the highest values, but this did not affect SP rates. D. Conclusions: Dialysis patients respond to influenza immunization adequately and similarly to the general population. Thus, annual vaccination policies should be encouraged in dialysis units. OL-HDF reduces chronic inflammation; however, this has no impact on SR rates.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pleros, Christos
  • Πλέρος, Χρήστος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56371

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pleros, Christos; Πλέρος, Χρήστος. Μελέτη της χρόνιας φλεγμονής και της ανοσολογικής απόκρισης στον εποχικό αντιγριπικό εμβολιασμό σε ασθενείς υπό χρόνια περιοδική αιμοκάθαρση: σύγκριση και πιθανά πλεονεκτήματα της online αιμοδιαδιήθησης σε σχέση με την κλασσική αιμοκάθαρση. Democritus University of Thrace (DUTH), 2024. http://hdl.handle.net/10442/hedi/56371